← Browse by Condition
Medical Condition
platinum resistant ovarian cancer
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 2
NCT07030907 Phase 1
Recruiting
A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer
Enrollment
30 pts
Location
United States
Sponsor
Outpace Bio, Inc.
NCT07470853 Phase 1
Recruiting
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
Enrollment
265 pts
Location
United States
Sponsor
Whitehawk Therapeutics, Inc.
NCT06321484 Phase 1
Recruiting
Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer
Enrollment
18 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
NCT04787289 Phase 2
Recruiting
A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer
Enrollment
244 pts
Location
Canada
Sponsor
British Columbia Cancer Agency